Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care
| Status: | Completed |
|---|---|
| Conditions: | Anxiety, Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 60 - Any |
| Updated: | 4/21/2016 |
| Start Date: | March 2004 |
| End Date: | April 2015 |
The purpose of this study is to determine whether cognitive behavior therapy (CBT) is
effective in the treatment of generalized anxiety disorder (GAD) in adults age 60 and older
in a primary care setting.
effective in the treatment of generalized anxiety disorder (GAD) in adults age 60 and older
in a primary care setting.
Generalized Anxiety Disorder (GAD) is one of the most common anxiety disorders among older
adults. Anxiety in older adults is associated with decreased physical activity, poorer
self-perceptions of health, decreased life satisfaction, and increased loneliness. Because
many older adults with anxiety seek assistance in a medical setting, treatment has been
primarily pharmacological. There is, however, limited evidence of the effectiveness of
psychotropic medications. Given the potential difficulties in prescribing psychotropic
medications in later life (e.g., increased adverse effects, potential drug interactions),
psychosocial treatments may be important alternative or adjuncts.
The treatment phase of this study lasts 10 weeks, during which patients will be randomly
assigned to either cognitive behavior therapy (CBT) or usual care. Follow-up will last 12
months after treatment completion, during which time patients will complete telephone
assessments.
adults. Anxiety in older adults is associated with decreased physical activity, poorer
self-perceptions of health, decreased life satisfaction, and increased loneliness. Because
many older adults with anxiety seek assistance in a medical setting, treatment has been
primarily pharmacological. There is, however, limited evidence of the effectiveness of
psychotropic medications. Given the potential difficulties in prescribing psychotropic
medications in later life (e.g., increased adverse effects, potential drug interactions),
psychosocial treatments may be important alternative or adjuncts.
The treatment phase of this study lasts 10 weeks, during which patients will be randomly
assigned to either cognitive behavior therapy (CBT) or usual care. Follow-up will last 12
months after treatment completion, during which time patients will complete telephone
assessments.
Inclusion Criteria:
- Clinical diagnosis of Generalized Anxiety Disorder
Exclusion Criteria:
- Active suicidal intent
- Current psychosis
- Current bipolar disorder
- Substance abuse within past month
- Cognitive impairment
We found this trial at
1
site
Click here to add this to my saved trials
